| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 208,166 | 164,594 | 163,970 | 308,636 |
| Accounts receivable, net | 566,881 | 560,563 | 527,464 | 511,250 |
| Inventories | 391,564 | 392,584 | 395,987 | 389,804 |
| Other current assets | 310,444 | 244,616 | 230,192 | 224,054 |
| Total current assets | 1,477,055 | 1,362,357 | 1,317,613 | 1,433,744 |
| Property and equipment, net | 739,437 | 739,677 | 717,624 | 717,745 |
| Operating lease right-of-use assets | 128,207 | 129,778 | 115,999 | 121,053 |
| Goodwill | 413,651 | 414,488 | 407,486 | 412,071 |
| Intangible assets, net | 114,790 | 103,729 | 107,408 | 106,885 |
| Other long-term assets | 513,572 | 580,765 | 547,559 | 559,268 |
| Total long-term assets | 1,909,657 | 1,968,437 | 1,896,076 | 1,917,022 |
| Total assets | 3,386,712 | 3,330,794 | 3,213,689 | 3,350,766 |
| Accounts payable | 122,265 | 116,585 | 120,096 | 110,603 |
| Accrued liabilities | 488,856 | 416,977 | 490,688 | 511,047 |
| Credit facility | 455,000 | 579,000 | 319,500 | 250,000 |
| Current portion of long-term debt | 149,997 | 74,994 | 170,929 | 99,140 |
| Current portion of deferred revenue | 35,693 | 36,324 | 35,000 | 38,434 |
| Total current liabilities | 1,251,811 | 1,223,880 | 1,136,213 | 1,009,224 |
| Deferred income tax liabilities | 3,724 | 2,088 | 8,110 | 5,658 |
| Long-term debt, net of current portion | 374,825 | 449,812 | 449,799 | 524,758 |
| Deferred revenue, net of current portion | 31,051 | 31,762 | 26,819 | 26,773 |
| Operating lease liabilities, net of current portion | 106,494 | 107,637 | 97,004 | 103,420 |
| Other long-term liabilities | 57,621 | 56,788 | 47,731 | 62,879 |
| Total long-term liabilities | 573,715 | 648,087 | 629,463 | 723,488 |
| Total liabilities | 1,825,526 | 1,871,967 | 1,765,676 | 1,732,712 |
| Common stock, 0.10 par value authorized 120,000 shares issued 108,301 shares in 2025 and 107,836 shares in 2024 outstanding 79,999 shares in 2025 and 81,604 shares in 2024 | 10,830 | 10,804 | 10,792 | 10,770 |
| Additional paid-in capital | 1,792,787 | 1,727,410 | 1,695,613 | 1,646,363 |
| Deferred stock units outstanding 60 units in 2025 and 60 units in 2024 | 6,229 | 6,229 | 5,856 | 5,885 |
| Retained earnings | 6,143,714 | 5,869,104 | 5,575,115 | 5,116,289 |
| Accumulated other comprehensive loss | -72,950 | -76,950 | -90,091 | -75,971 |
| Treasury stock, at cost 28,303 shares in 2025 and 26,232 shares in 2024 | 6,319,424 | 6,077,770 | 5,749,272 | 5,085,282 |
| Total stockholders equity | 1,561,186 | 1,458,827 | 1,448,013 | 1,618,054 |
| Total liabilities and stockholders equity | 3,386,712 | 3,330,794 | 3,213,689 | 3,350,766 |
IDEXX LABORATORIES INC DE (IDXX)
IDEXX LABORATORIES INC DE (IDXX)